UniProt ID | SARNP_HUMAN | |
---|---|---|
UniProt AC | P82979 | |
Protein Name | SAP domain-containing ribonucleoprotein | |
Gene Name | SARNP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 210 | |
Subcellular Localization | Nucleus. Nucleus speckle. | |
Protein Description | Binds both single-stranded and double-stranded DNA with higher affinity for the single-stranded form. Specifically binds to scaffold/matrix attachment region DNA. Also binds single-stranded RNA. Enhances RNA unwinding activity of DDX39A. May participate in important transcriptional or translational control of cell growth, metabolism and carcinogenesis. Component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production.. | |
Protein Sequence | MATETVELHKLKLAELKQECLARGLETKGIKQDLIHRLQAYLEEHAEEEANEEDVLGDETEEEETKPIELPVKEEEPPEKTVDVAAEKKVVKITSEIPQTERMQKRAERFNVPVSLESKKAARAARFGISSVPTKGLSSDNKPMVNLDKLKERAQRFGLNVSSISRKSEDDEKLKKRKERFGIVTSSAGTGTTEDTEAKKRKRAERFGIA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATETVELH ------CCCCHHHHH | 17.72 | 22223895 | |
10 | 2-Hydroxyisobutyrylation | TETVELHKLKLAELK CCHHHHHHHHHHHHH | 61.00 | - | |
10 | Acetylation | TETVELHKLKLAELK CCHHHHHHHHHHHHH | 61.00 | 23954790 | |
10 | Ubiquitination | TETVELHKLKLAELK CCHHHHHHHHHHHHH | 61.00 | 21890473 | |
10 | Malonylation | TETVELHKLKLAELK CCHHHHHHHHHHHHH | 61.00 | 32601280 | |
12 | 2-Hydroxyisobutyrylation | TVELHKLKLAELKQE HHHHHHHHHHHHHHH | 50.91 | - | |
12 | Malonylation | TVELHKLKLAELKQE HHHHHHHHHHHHHHH | 50.91 | 26320211 | |
17 | Ubiquitination | KLKLAELKQECLARG HHHHHHHHHHHHHCC | 35.24 | 32015554 | |
17 | Acetylation | KLKLAELKQECLARG HHHHHHHHHHHHHCC | 35.24 | 25953088 | |
20 | Glutathionylation | LAELKQECLARGLET HHHHHHHHHHCCCCC | 3.14 | 22555962 | |
28 | Malonylation | LARGLETKGIKQDLI HHCCCCCCCHHHHHH | 49.62 | 26320211 | |
28 | Ubiquitination | LARGLETKGIKQDLI HHCCCCCCCHHHHHH | 49.62 | 32015554 | |
31 | Acetylation | GLETKGIKQDLIHRL CCCCCCHHHHHHHHH | 46.56 | 26051181 | |
31 | Ubiquitination | GLETKGIKQDLIHRL CCCCCCHHHHHHHHH | 46.56 | 24816145 | |
31 | 2-Hydroxyisobutyrylation | GLETKGIKQDLIHRL CCCCCCHHHHHHHHH | 46.56 | - | |
31 | Succinylation | GLETKGIKQDLIHRL CCCCCCHHHHHHHHH | 46.56 | 23954790 | |
60 | Phosphorylation | EDVLGDETEEEETKP CCCCCCCCCCCCCCC | 54.13 | 29507054 | |
65 | Phosphorylation | DETEEEETKPIELPV CCCCCCCCCCCCCCC | 45.46 | 30576142 | |
66 | Sumoylation | ETEEEETKPIELPVK CCCCCCCCCCCCCCC | 47.48 | - | |
66 | Sumoylation | ETEEEETKPIELPVK CCCCCCCCCCCCCCC | 47.48 | - | |
80 | Ubiquitination | KEEEPPEKTVDVAAE CCCCCCCCCCCHHHH | 60.67 | 33845483 | |
81 | Phosphorylation | EEEPPEKTVDVAAEK CCCCCCCCCCHHHHH | 21.92 | 26074081 | |
88 | Ubiquitination | TVDVAAEKKVVKITS CCCHHHHHCEEEEEC | 46.25 | 33845483 | |
88 | Acetylation | TVDVAAEKKVVKITS CCCHHHHHCEEEEEC | 46.25 | 23749302 | |
89 | Ubiquitination | VDVAAEKKVVKITSE CCHHHHHCEEEEECC | 43.71 | 22817900 | |
92 | Acetylation | AAEKKVVKITSEIPQ HHHHCEEEEECCCCC | 43.16 | 26822725 | |
92 | Ubiquitination | AAEKKVVKITSEIPQ HHHHCEEEEECCCCC | 43.16 | 22817900 | |
100 | Phosphorylation | ITSEIPQTERMQKRA EECCCCCHHHHHHHH | 21.87 | 28555341 | |
115 | O-linked_Glycosylation | ERFNVPVSLESKKAA HHHCCCCCHHHHHHH | 21.98 | 30620550 | |
115 | Phosphorylation | ERFNVPVSLESKKAA HHHCCCCCHHHHHHH | 21.98 | 25159151 | |
118 | Phosphorylation | NVPVSLESKKAARAA CCCCCHHHHHHHHHH | 44.76 | 21815630 | |
119 | Ubiquitination | VPVSLESKKAARAAR CCCCHHHHHHHHHHH | 36.74 | 32015554 | |
119 | 2-Hydroxyisobutyrylation | VPVSLESKKAARAAR CCCCHHHHHHHHHHH | 36.74 | - | |
119 | Acetylation | VPVSLESKKAARAAR CCCCHHHHHHHHHHH | 36.74 | 23749302 | |
120 | Acetylation | PVSLESKKAARAARF CCCHHHHHHHHHHHH | 57.46 | 30586061 | |
130 | Phosphorylation | RAARFGISSVPTKGL HHHHHCCCCCCCCCC | 26.18 | 28857561 | |
131 | Phosphorylation | AARFGISSVPTKGLS HHHHCCCCCCCCCCC | 30.14 | 28857561 | |
134 | Phosphorylation | FGISSVPTKGLSSDN HCCCCCCCCCCCCCC | 35.27 | 23186163 | |
135 | Acetylation | GISSVPTKGLSSDNK CCCCCCCCCCCCCCC | 52.35 | 25953088 | |
135 | Ubiquitination | GISSVPTKGLSSDNK CCCCCCCCCCCCCCC | 52.35 | 22817900 | |
135 | Methylation | GISSVPTKGLSSDNK CCCCCCCCCCCCCCC | 52.35 | - | |
138 | Phosphorylation | SVPTKGLSSDNKPMV CCCCCCCCCCCCCCC | 44.29 | 24247654 | |
139 | Phosphorylation | VPTKGLSSDNKPMVN CCCCCCCCCCCCCCC | 50.69 | 25159151 | |
142 | Acetylation | KGLSSDNKPMVNLDK CCCCCCCCCCCCHHH | 39.21 | 23954790 | |
142 | Ubiquitination | KGLSSDNKPMVNLDK CCCCCCCCCCCCHHH | 39.21 | 24816145 | |
144 | Sulfoxidation | LSSDNKPMVNLDKLK CCCCCCCCCCHHHHH | 3.13 | 21406390 | |
149 | Acetylation | KPMVNLDKLKERAQR CCCCCHHHHHHHHHH | 65.70 | 26822725 | |
149 | Ubiquitination | KPMVNLDKLKERAQR CCCCCHHHHHHHHHH | 65.70 | 33845483 | |
162 | Phosphorylation | QRFGLNVSSISRKSE HHHCCCHHHHCCCCC | 22.38 | 25159151 | |
163 | Phosphorylation | RFGLNVSSISRKSED HHCCCHHHHCCCCCC | 21.94 | 23401153 | |
165 | Phosphorylation | GLNVSSISRKSEDDE CCCHHHHCCCCCCHH | 35.29 | 21712546 | |
168 | Phosphorylation | VSSISRKSEDDEKLK HHHHCCCCCCHHHHH | 45.18 | 21712546 | |
173 | Ubiquitination | RKSEDDEKLKKRKER CCCCCHHHHHHHHHH | 73.02 | 24816145 | |
185 | O-linked_Glycosylation | KERFGIVTSSAGTGT HHHHCEEECCCCCCC | 18.29 | 30620550 | |
185 | Phosphorylation | KERFGIVTSSAGTGT HHHHCEEECCCCCCC | 18.29 | 28555341 | |
186 | O-linked_Glycosylation | ERFGIVTSSAGTGTT HHHCEEECCCCCCCC | 13.80 | 30620550 | |
186 | Phosphorylation | ERFGIVTSSAGTGTT HHHCEEECCCCCCCC | 13.80 | 28555341 | |
187 | O-linked_Glycosylation | RFGIVTSSAGTGTTE HHCEEECCCCCCCCC | 22.73 | 30620550 | |
187 | Phosphorylation | RFGIVTSSAGTGTTE HHCEEECCCCCCCCC | 22.73 | 25849741 | |
190 | Phosphorylation | IVTSSAGTGTTEDTE EEECCCCCCCCCCHH | 30.95 | 21815630 | |
192 | Phosphorylation | TSSAGTGTTEDTEAK ECCCCCCCCCCHHHH | 27.18 | 28555341 | |
193 | Phosphorylation | SSAGTGTTEDTEAKK CCCCCCCCCCHHHHH | 32.96 | 28985074 | |
196 | Phosphorylation | GTGTTEDTEAKKRKR CCCCCCCHHHHHHHH | 31.45 | 28985074 | |
199 | Acetylation | TTEDTEAKKRKRAER CCCCHHHHHHHHHHH | 47.05 | 25953088 | |
199 | Ubiquitination | TTEDTEAKKRKRAER CCCCHHHHHHHHHHH | 47.05 | 21906983 | |
200 | Ubiquitination | TEDTEAKKRKRAERF CCCHHHHHHHHHHHH | 70.92 | 22817900 | |
200 | Acetylation | TEDTEAKKRKRAERF CCCHHHHHHHHHHHH | 70.92 | 25953088 | |
202 | Ubiquitination | DTEAKKRKRAERFGI CHHHHHHHHHHHHCC | 65.91 | 22817900 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SARNP_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SARNP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SARNP_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-142, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-163, AND MASSSPECTROMETRY. |